Evidence map›Paper›PMID 37966587›Full record

SynthesisNeurosurgical review2023

SARS-CoV-2 infection and spontaneous spinal hemorrhage: a systematic review.

Arman Sourani, Noushin Vahdat, Colin Son, Omid R Hariri, Majid Rezvani, Mina Foroughi, Ryan Mirza, Armin Sourani, Sadegh Baradaran Mahdavi

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Arman SouraniDepartment of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran. armansourani@gmail.com.ORCID https://orcid.org/0000-0002-8998-9446
Noushin VahdatDepartment of Radiology University of California, San Diego Health, San Diego, CA, USA.ORCID https://orcid.org/0000-0003-0924-2332
Colin SonNeurosurgical Associates of San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0002-1782-0537
Omid R HaririDepartment of Neurological Surgery, Kaiser Permanente Orange County, Anaheim, CA, USA.ORCID https://orcid.org/0000-0003-3203-3424
Majid RezvaniDepartment of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-9394-7150
Mina ForoughiStudent Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0001-6640-7493
Ryan MirzaDepartment of Radiology University of California, San Diego Health, San Diego, CA, USA.ORCID https://orcid.org/0009-0000-8616-2315
Armin SouraniStudent Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0003-3618-9987
Sadegh Baradaran MahdaviDepartment of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. sadegh.b.mahdavi@resident.mui.ac.ir.ORCID https://orcid.org/0000-0002-1956-1372
Isfahan University of Medical Sciences · IRUC San Diego Health System · USKaiser Permanente Anaheim Medical Center · USUniversity of the Incarnate Word · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including spontaneous spinal hemorrhage (SSH), are diverse. SSH is a detrimental neurosurgical event requiring immediate medical attention. We aimed to investigate the association between SARS-CoV-2 and SSH and delineate a rational clinical approach. The authors searched PubMed, Scopus, Web of Science, and Google Scholar for studies published up to January 25, 2023, on SSH and SARS-CoV-2 infection. For each dataset, the authors performed pooled estimates examining three outcomes of interest: (1) early post-intervention neurological status, (2) mortality, and (3) post-intervention neurological rehabilitation outcomes. After reviewing 1341 results, seven datasets were identified for the final analysis. Fifty-seven percent of patients were females. Twenty-eight percent of the patients experienced severe systemic infection. The mean interval between the SARS-CoV-2 infection and neurological presentation was 18 days. Pain and sensorimotor deficits were the most common (57%). Spinal epidural hematoma (EDH) was the most common presentation (71.4%). Three patients were treated conservatively, while 4 received neurosurgical intervention. Pain and sensorimotor deficits had the best treatment response (100%), while the sphincter had the worst response (0%). Long-term follow-up showed that 71% of patients had good recovery. SARS-CoV-2-associated SSH is a rare complication of infection, with an often insidious presentation that requires high clinical suspicion. Patients with SARS-CoV-2 infection and new neurological symptoms or disproportionate neck or back pain require a neuroaxis evaluation. Neurosurgical intervention and conservative management are both viable options to treat SSH following COVID-19. Still, a homogenous approach to the treatment paradigm of SSH cannot be obtained, but lesions with space-occupying effects are suitable for neurosurgical evacuation-decompression while more indolent lesions could be treated conservatively. These options should be tailored individually until larger studies provide a consensus.

Indexed as

COVID-19SARS-CoV-2Spinal Cord DiseasesFemaleHematomaHematoma, Epidural, SpinalHumansMaleNeurosurgical ProceduresPainCOVID-19SARS-CoV-2Spinal cord vascular diseasesSpontaneous spinal hemorrhage

Identifiers

PMID37966587
OpenAlexW4388705526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.